Search

Your search keyword '"Pei, Lixia"' showing total 9 results

Search Constraints

Start Over You searched for: Author "Pei, Lixia" Remove constraint Author: "Pei, Lixia" Topic antineoplastic combined chemotherapy protocols Remove constraint Topic: antineoplastic combined chemotherapy protocols
9 results on '"Pei, Lixia"'

Search Results

1. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

2. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study .

3. Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study.

4. Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study.

5. Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials.

6. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.

7. Teclistamab versus real-world physicians choice of therapy in triple-class exposed relapsed/refractory multiple myeloma.

8. Teclistamab in Relapsed or Refractory Multiple Myeloma

9. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma

Catalog

Books, media, physical & digital resources